Amplifon SpA
AMP · Borsa Italiana · Italy
Price data from its 0N61 listing on LSE
corporate.amplifon.comFinancials as of FY2025
Sources hearing devices from outside manufacturers and earns by fitting, personalizing and servicing them for customers through an owned and franchised clinic network and managed-care arrangements with insurers.
- Depends onMidstream position: 6 outgoing, 7 incoming connections
- ScaleMarket cap is $3.38B, above the global median of $1.2B
- FinancialsAltman Z-Score 1.62: grey zone
- Interpretations2 currently firing — 2
What this company is and how it runs — written from structure, not news.
The system sits between hearing device manufacturers upstream and individual customers downstream, taking a manufactured product and coordinating the fitting, personalization and follow-up care built around it. In its managed-care arrangements it also coordinates between insurers, the health-plan members they cover, and the network of shops and independent retailers that deliver the service to them.
Revenue comes mainly from selling the hearing device itself, with a smaller share billed separately for testing, fitting and ongoing adjustment services. Franchisees pay it for the products and higher value services they in turn resell, and in its managed-care arrangements it is paid by insurers to manage hearing-benefit service delivery for their members, rather than being paid by the member directly.
It scales less by expanding manufacturing capacity than by adding points of care, operating a mix of directly owned stores, franchised locations and shop-in-shop counters, and by acquiring existing independent clinics in target markets while also closing its weaker-performing locations elsewhere. CompanyGraph's reading of its financial pattern shows this expansion running alongside a capital structure with debt that is large relative to equity, total assets and operating cash flow, next to cash generation that has stayed positive and recently exceeded reported accounting profit.
It depends on outside manufacturers for the hearing devices and accessories it sells rather than making them itself, so the continuity of its suppliers' production and distribution is a named dependency. It also names trade-tariff policy and severe weather at supplier sites as risks that reach its supply, and points to a spread of suppliers and sourcing geographies as how it reduces reliance on any single one.
Individual customers with hearing loss depend on it for the device together with the fitting and ongoing adjustment care that comes with it. Franchisees depend on it as the supplier of the products and higher value services they resell, and in the United States, insurance companies depend on it to manage hearing-benefit service delivery to the health-plan members they cover.
The company itself points to the scale of its distribution network, its portfolio of brands, its people and its innovation, along with its distribution data and global processes, as the basis of its position, and describes itself as the leader in its market by share. CompanyGraph's mapping, however, places a large number of other companies in the same basic operating shape, a flow business that converts a sourced product into a fitted service under a throughput constraint. That shape is therefore common rather than distinctive, and its commonality does not show that competitors are unable to copy it.
CompanyGraph's industry-level starting point for a flow business that converts a sourced product into a fitted service is a ceiling on throughput or capacity. The company's own account of its recent performance points elsewhere: it describes a demand-side limit, a market growing more slowly than in the past and softer patient confidence during periods of wider tension, together with lower returns on its fixed store and staff base when fewer customers come through. On its own account, what currently limits it looks more like customers' willingness to buy than any ceiling on how many it could serve.
Voting control sits concentrated in a single controlling shareholder holding a majority of voting rights under an enhanced-voting-rights structure, so major decisions rest with one holder rather than being distributed across a broad shareholder base. On its own account, the business is also sensitive to macroeconomic and geopolitical conditions strong enough to weaken consumer confidence, since buying a hearing device is a purchase a household can postpone in a way a more essential purchase cannot.
It names macroeconomic and geopolitical conditions, including conflict, elections, inflation and interest rates, as a pressure able to weaken consumer confidence and lead people to put off buying a hearing device. It also names trade-tariff policy and severe weather affecting its suppliers' production and distribution sites as outside pressures that can reach it through its supply chain.
Read from the company's own filings and public materials (gathered August 2026) together with figures CompanyGraph recomputed from its statements. Written September 2026. A question with no evidence behind it is left out rather than answered.
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
The reported statements, read against the company's own industry.
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.